All sites C00-96,D32-33,D42-43,D45-47,D76 256 88.7 4.3 3.9 1.0 2.1
Mouth, pharynx C00-14 6 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 51 85.0 3.9 7.1 1.2 2.8
  Oesophagus C15 4 100.0 - - - -
  Stomach C16 8 100.0 - - - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 12 93.2 - 5.1 - 1.7
  Rectum, rectosigmoid C19-20 8 97.6 - 2.4 - -
  Anus C21 0 100.0 - - - -
  Liver C22 5 84.6 - 15.4 - -
  Gallbladder, bile ducts C23-24 1 66.7 33.3 - - -
  Pancreas C25 11 53.6 14.3 17.9 5.4 8.9
  Other digestive organs C26 0 50.0 - - - 50.0
Respiratory organs C30-39 41 66.5 15.8 10.3 3.0 4.4
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 2 90.0 10.0 - - -
  Lung, trachea C33-34 38 64.6 16.4 11.1 3.2 4.8
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 - - - - - -
Melanoma of the skin C43 8 100.0 - - - -
Skin, non-melanoma C44 15 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 75.0 25.0 - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 74 99.2 - 0.3 0.5 -
  Prostate C61 72 99.2 - 0.3 0.6 -
  Testis C62 1 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 21 96.2 0.9 0.9 0.9 0.9
  Kidney C64 11 94.3 1.9 1.9 1.9 -
  Bladder and urinary tract2 C65-68 11 98.1 - - - 1.9
Eye C69 1 66.7 - - 33.3 -
Brain, central nervous system C70-72,D32-33,D42-43 5 88.9 - 7.4 - 3.7
Thyroid gland C73 3 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 5 66.7 11.1 11.1 - 11.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 24 85.0 6.7 3.3 - 5.0
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 12 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 5 56.5 21.7 8.7 - 13.0
  Leukaemia C91-95 4 80.0 5.0 10.0 - 5.0
  Myelodysplastic syndromes D46 1 50.0 25.0 - - 25.0
  Myeloproliferaitive neoplasms D45,D47 1 50.0 25.0 - - 25.0
Not included above
  Basal cell carcinoma of the skin 61 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.